Skip to main content
. 2008 Nov 18;5(11):e227. doi: 10.1371/journal.pmed.0050227

Table 1.

Potential Outcome Scenarios of Antimalarial Phase III Trials with a Chemotherapeutic Endpoint and Their Proposed Interpretation

graphic file with name pmed.0050227.t001.jpg